Literature DB >> 15681459

Inhibition of cell division by the human cytomegalovirus IE86 protein: role of the p53 pathway or cyclin-dependent kinase 1/cyclin B1.

Yoon-Jae Song1, Mark F Stinski.   

Abstract

The human cytomegalovirus (HCMV) IE86 protein induces the human fibroblast cell cycle from G(0)/G(1) to G(1)/S, where cell cycle progression stops. Cells with a wild-type, mutated, or null p53 or cells with null p21 protein were transduced with replication-deficient adenoviruses expressing HCMV IE86 protein or cellular p53 or p21. Even though S-phase genes were activated in a p53 wild-type cell, IE86 protein also induced phospho-Ser(15) p53 and p21 independent of p14ARF but dependent on ATM kinase. These cells did not enter the S phase. In human p53 mutant, p53 null, or p21 null cells, IE86 protein did not up-regulate p21, cellular DNA synthesis was not inhibited, but cell division was inhibited. Cells accumulated in the G(2)/M phase, and there was increased cyclin-dependent kinase 1/cyclin B1 activity. Although the HCMV IE86 protein increases cellular E2F activity, it also blocks cell division in both p53(+/+) and p53(-/-) cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681459      PMCID: PMC546562          DOI: 10.1128/JVI.79.4.2597-2603.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

Review 1.  Progression into and out of mitosis.

Authors:  W Zachariae
Journal:  Curr Opin Cell Biol       Date:  1999-12       Impact factor: 8.382

Review 2.  Splitting the chromosome: cutting the ties that bind sister chromatids.

Authors:  K Nasmyth; J M Peters; F Uhlmann
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

3.  Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.

Authors:  Mikael S Lindström; Klas G Wiman
Journal:  Oncogene       Date:  2003-08-07       Impact factor: 9.867

Review 4.  Regulation of the APC and the exit from mitosis.

Authors:  D O Morgan
Journal:  Nat Cell Biol       Date:  1999-06       Impact factor: 28.824

Review 5.  Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

Review 6.  PCNA binding proteins.

Authors:  T Tsurimoto
Journal:  Front Biosci       Date:  1999-12-01

Review 7.  Decision making by p53: life, death and cancer.

Authors:  M Oren
Journal:  Cell Death Differ       Date:  2003-04       Impact factor: 15.828

Review 8.  The RB and p53 pathways in cancer.

Authors:  Charles J Sherr; Frank McCormick
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

9.  E2F and Ras synergize in transcriptionally activating p14ARF expression.

Authors:  Eli Berkovich; Yocheved Lamed; Doron Ginsberg
Journal:  Cell Cycle       Date:  2003 Mar-Apr       Impact factor: 4.534

10.  Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein.

Authors:  C Hagemeier; R Caswell; G Hayhurst; J Sinclair; T Kouzarides
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

View more
  25 in total

1.  HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.

Authors:  Taisuke Izumi; Katsuhiro Io; Masashi Matsui; Kotaro Shirakawa; Masanobu Shinohara; Yuya Nagai; Masahiro Kawahara; Masayuki Kobayashi; Hiroshi Kondoh; Naoko Misawa; Yoshio Koyanagi; Takashi Uchiyama; Akifumi Takaori-Kondo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-11       Impact factor: 11.205

2.  Growth inhibition of human hepatocellular carcinoma cells by overexpression of G-protein-coupled receptor kinase 2.

Authors:  Zhengyu Wei; Reginald Hurtt; Michele Ciccarelli; Walter J Koch; Cataldo Doria
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

Review 3.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

4.  Potential role for p53 in the permissive life cycle of human cytomegalovirus.

Authors:  N C Casavant; M H Luo; K Rosenke; T Winegardner; A Zurawska; E A Fortunato
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  The autoregulatory and transactivating functions of the human cytomegalovirus IE86 protein use independent mechanisms for promoter binding.

Authors:  Dustin T Petrik; Kimberly P Schmitt; Mark F Stinski
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

6.  Mutation of glutamine to arginine at position 548 of IE2 86 in human cytomegalovirus leads to decreased expression of IE2 40, IE2 60, UL83, and UL84 and increased transcription of US8-9 and US29-32.

Authors:  Sarah W Burgdorf; Charles L Clark; James R Burgdorf; Deborah H Spector
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

7.  Evidence that the human cytomegalovirus IE2-86 protein binds mdm2 and facilitates mdm2 degradation.

Authors:  Zhigang Zhang; David L Evers; Joseph F McCarville; Jean-Christophe Dantonel; Shu-Mei Huong; Eng-Shang Huang
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response.

Authors:  Jonathan P Castillo; Fiona M Frame; Harry A Rogoff; Mary T Pickering; Andrew D Yurochko; Timothy F Kowalik
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Cell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells.

Authors:  Lüder Wiebusch; Anke Neuwirth; Linus Grabenhenrich; Sebastian Voigt; Christian Hagemeier
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

10.  Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.

Authors:  Eung-Soo Hwang; Zhigang Zhang; Haobin Cai; David Y Huang; Shu-Mei Huong; Chang-Yong Cha; Eng-Shang Huang
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.